**Author details**

Miriam Rodríguez-Esquivel1 \*, José Alejandro Sánchez-Pérez2 , Héctor Guerrero-Flores3 , Emmanuel Salcedo1 , Teresa Apresa-García1 , Ricardo López-Romero1 , Alejandra Valdivia-Flores4 , Florinda Jiménez-Vega5 , Rodrigo Aldariz1 and Mauricio Salcedo1 \*

1 Medical Research Unit in Oncological Diseases, Oncology Hospital, National Medical Center Century XXI, Mexican Institute of Social Security, Mexico City, Mexico

2 Canine Detector Group Mexico, Mexico City, México

3 Mexican Institute of Social Security, Southern Delegation Medical Coordinator, Mexico City, Mexico

4 Instituto Politécnico Nacional, Escuela Superior de Enfermería y Obstetricia, Mexico City, México

5 Institute of Biomedical Sciences, Autonomous University of Juarez City, Juarez City, Mexico

\*Address all correspondence to: miririamre@gmail.com and masava89@gmail.com

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**151**

2014;2014:1-15.

*Canine Detection of the Volatile Organic Compounds Related to Cervical Cancer Cells*

cancer screening in 57 countries: Low average levels and large inequalities. PLoS Med. 2008;5(6):0863-8.

[11] Petry KU, Wörmann B, Schneider A.

[12] Shah SS, Senapati S, Klacsmann F, Miller DL, Johnson JJ, Chang HC, et al. Current technologies and recent developments for screening of HPVassociated cervical and oropharyngeal cancers. Cancers (Basel). 2016;8(9):1-27.

[13] Coleman D. Limitations of the cervical smear test as a method of detecting women at risk of cervical cancer. AVMA Med Leg J Limitations.

[14] Schiffman M, Sanjose S de. False positive cervical HPV screening test results. Papillomavirus Res J.

[15] Coscia MF, Monno R, Ballini A, Mirgaldi R, Dipalma G, Pettini F, et al. Human papilloma virus (HPV) genotypes prevalence in a region of South Italy (Apulia). Ann Ist Super

[16] Kops NL, Bessel M, Horvath JDC,

Benzaken AS, et al. Factors associated with HPV and other self-reported STI coinfections among sexually active Brazilian young adults: cross-sectional nationwide study. BMJ Open. 2019;1-7.

[17] Sousa DMDN, Chagas ACMA, Vasconcelos CTM, Stein AT, Oriá MOB. Development of a clinical protocol for detection of cervical cancer precursor lesions. Rev Latino-Am Enferm.

[18] Ranabhat S, Dhungana G,

Neupane M, Shrestha R, Tiwari M. Pap

2018;26(e2999).

Sanità. 2015;51(3):248-51.

Domingues C, Souza FMA de,

Benefits and risks of cervical cancer screening. Oncol Res Treat.

2014;37:48-57.

2015;7(6):235-40.

2019;7:184-7.

*DOI: http://dx.doi.org/10.5772/intechopen.95773*

[1] Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):

[2] Porcari AM, Negrão F, Tripodi GL, Pitta DR, Campos EA, Montis DM, et al. Molecular Signatures of High-Grade Cervical Lesions. Front Oncol.

[3] Weiderpass E, Labrèche F. Malignant Tumors of the Female Reproductive System. Saf Heal Work. 2012;3:166-80.

[4] Adanu RMK. Eradicating cervical cancer. Int J Gynecol Obs. 2020;148:1-2.

[6] Angle C, Waggoner LP, Ferrando A, Haney P, Otto CM, Goldblatt A, et al. Canine detection of the Volatilome: a review of implications for pathogen and disease detection. Front Vet Sci.

[7] Ranjan K, Singh R. Dog Nose to E-Nose in Disease Diagnosis Koushlesh.

J Adv Biol. 2018;11:2294-306.

[8] LaVigne AW, Triedman SA, Randall TC, Trimble EL,

barriers to radiotherapy delivery. Gynecol Oncol Reports [Internet]. 2017;22:16-20. Available from: https:// doi.org/10.1016/j.gore.2017.08.004

[9] Jusman Y, Ng SC, Osman NAA. Intelligent Screening Systems for Cervical Cancer. Sci World Journa.

[10] Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical

Viswanathan AN. Cervical cancer in low and middle income countries: Addressing

[5] Aranda S, Berkley S, Cowal S, Dybul M, Evans T, Iversen K, et al. Ending cervical cancer: A call to action. Int J Gynecol Obs 2017; 2017;138:4-6.

**References**

444-58.

2018;8(99):1-9.

2016;3(47):1-7.

*Canine Detection of the Volatile Organic Compounds Related to Cervical Cancer Cells DOI: http://dx.doi.org/10.5772/intechopen.95773*
